To successfully navigate a government investigation of a licensed cannabis client, an attorney needs to assess which government agency (or agencies) is conducting the investigation, what are the potential outcomes, and what conflicts of interest may exist – all while taking in information in real time and often dealing with stressed clients. Any attorney may need to conduct an internal investigation at the same – and consider when to step aside and call in an expert. This panel will discuss responding to subpoenas, dealing with evolving disciplinary rules, respecting the Fourth and Fifth Amendment rights of individuals, and properly providing Upjohn warnings.
Pathways to Ending Federal Prohibition: An Overview of Descheduling & Rescheduling. In 2022, President Biden directed his administration to conduct a review of the status of cannabis under the Controlled Substances Act. This session examines the review process for descheduling and rescheduling and their potential impacts.
Interstate Commerce in Practice: What will Interstate commerce actually look like, and how will it be regulated? Assuming interstate commerce will commence before federal legalization, this session will probe the nuances of the federal government's posture toward state-regulated interstate sales will impact how products can effectively move from state to state. Presenters will discuss the practical challenges for regulators and operators in establishing an efficient and well-regulated interstate market.
Learn about the licensing considerations, continuing obligations, and risk related to physical security in the cannabis industry, from mapping your business to liaising with law enforcement, and from environmental and procedural security to best practices in security employee training, join us to go through the intricacies of security in the cannabis industry.
Niall will discuss cannabis jurisdiction, legislation, regulation, Medical Cannabis Access Programme (MCAP, the Specified Controlled Drugs (Cannabis-Based Medical Products), indications, CBD - Novel Foods (Conflict of Laws), and adult use in the Republic of Ireland.
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
This session will provide you with practice and practical advice on how to conduct due diligence on an IP portfolio in various types of transactions. The panel will identify top diligence issues so you can spot them in the next transaction you handle, and we'll discuss how to address them.
Those already in the cannabis industry and those looking to get into it will get a chance to learn more about newest adult-use markets in the country, how they compare to one another, and what we can anticipate as these new opportunities take shape.
Global Cannabis Intellectual Property Symposium 2023 session: Ethics: Balancing Activism and Zealous Advocacy with the Boundaries of the Profession and Evolving Law